First Trust Advisors
NBSE

First Trust Advisors’s NeuBase Therapeutics, Inc. Common Stock NBSE Stock Holding History

First Trust Advisors’s Portfolio NBSE Stock Details NBSE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-3,655
Closed -$350K – 2666
2021
Q2 		$350K Buy
3,655
+972
+36% +$93.1K ﹤0.01% 2351
2021
Q1 		$397K Buy
2,683
+222
+9% +$32.8K ﹤0.01% 2277
2020
Q4 		$344K Sell
2,461
-112
-4% -$15.7K ﹤0.01% 2201
2020
Q3 		$391K Buy
+2,573
New +$391K ﹤0.01% 2106